Literature DB >> 24398391

Immune and endocrine function in patients with burning mouth syndrome.

Kazuyoshi Koike1, Takahiro Shinozaki, Kazuhiko Hara, Noboru Noma, Akiko Okada-Ogawa, Masatake Asano, Masamichi Shinoda, Eli Eliav, Richard H Gracely, Koichi Iwata, Yoshiki Imamura.   

Abstract

OBJECTIVES: Research suggests that varied etiologic factors are responsible for burning mouth syndrome (BMS). We examined the role of immune and endocrine function in the pathology of BMS.
METHODS: We conducted a case-control study to evaluate immune (lymphocyte subpopulations) and endocrine (hypothalamus-pituitary-adrenal axis and sympathetic-adrenomedullary system) function in 47 female BMS patients and 47 age-matched female controls presenting at an university clinic. Psychological state was assessed with the Zung Self-Rating Depression Scale and Taylor Manifest Anxiety Scale.
RESULTS: BMS patients were significantly more anxious than controls (P=0.011). Plasma adrenaline level was significantly lower (P=0.020) in BMS patients than in controls, and linear regression analysis of all patients combined revealed that depression level was significantly positively associated with plasma noradrenaline and cortisol levels (P=0.002 and 0.001, respectively). However, as compared with controls, BMS patients had a significantly lower CD8(+) cell count (P<0.001) and a significantly higher CD4/CD8 ratio (P=0.002). Discriminant analysis revealed that CD8(+) cell count and CD4/CD8 ratio were independent variables that distinguished BMS patients from controls. DISCUSSION: The immunoendocrine system is substantially involved, and may have a key role, in the mechanism of chronic pain in BMS patients. Immune function was significantly and specifically suppressed in BMS, although the hypothalamic-pituitary-adrenal axis and sympathetic nervous system were predominantly activated by psychological stress that was not specific to BMS.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24398391     DOI: 10.1097/AJP.0b013e31828c4bf1

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  6 in total

Review 1.  Interventions for treating burning mouth syndrome.

Authors:  Roddy McMillan; Heli Forssell; John Ag Buchanan; Anne-Marie Glenny; Jo C Weldon; Joanna M Zakrzewska
Journal:  Cochrane Database Syst Rev       Date:  2016-11-18

2.  Altered structural connectivity of pain-related brain network in burning mouth syndrome-investigation by graph analysis of probabilistic tractography.

Authors:  Akihiko Wada; Takashi Shizukuishi; Junko Kikuta; Haruyasu Yamada; Yusuke Watanabe; Yoshiki Imamura; Takahiro Shinozaki; Ko Dezawa; Hiroki Haradome; Osamu Abe
Journal:  Neuroradiology       Date:  2017-03-30       Impact factor: 2.804

Review 3.  Insight into the Role of Psychological Factors in Oral Mucosa Diseases.

Authors:  Yuexin Guo; Boya Wang; Han Gao; Chengwei He; Rongxuan Hua; Lei Gao; Yixuan Du; Jingdong Xu
Journal:  Int J Mol Sci       Date:  2022-04-26       Impact factor: 6.208

4.  Refractory burning mouth syndrome: clinical and paraclinical evaluation, comorbiities, treatment and outcome.

Authors:  Dimos D Mitsikostas; Srdjan Ljubisavljevic; Christina I Deligianni
Journal:  J Headache Pain       Date:  2017-03-29       Impact factor: 7.277

5.  The Complaints, Type, and Severity of Stressful Events in Patients with Burning Mouth Syndrome Referring to Zahedan School of Dentistry, Iran.

Authors:  Tahereh Nosratzehi; Abolfazl Payandeh; Farnaz DehYadegari
Journal:  Clin Cosmet Investig Dent       Date:  2020-04-09

6.  Comparison of Clonazepam and Tongue Protector in the Treatment of Burning Mouth Syndrome.

Authors:  Jacek Zborowski; Tomasz Konopka
Journal:  Int J Environ Res Public Health       Date:  2022-07-24       Impact factor: 4.614

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.